2026 ACCP STEP & ESP Webinar: Exposure Response Analysis Across the Drug Development Continuum: Foundational Principles - LIVE
Includes a Live Web Event on 03/11/2026 at 1:00 PM (EDT)
-
You must log in to register
- User - Free!
- Member - Free!
2026 ACCP STEP & ESP Webinar: Exposure-Response Analysis Across the Drug Development Continuum: Foundational Principles
Live Session: Wednesday, March 11th, 2026, from 1:00 to 2:00 PM ET
On Demand: March 11th, 2026 to March 11th, 2029
Target audience:
Interprofessional team of MDs, PharmDs, PhDs and other healthcare professionals who are interested in the foundational E-R principles and practical strategies that can be applied within regulatory, industry, and academic settings.
Objectives
After completing this activity, the learner will be able to:
- Identify decisions to support, model influence, model risk and model impact;
- Discuss key considerations when creating a qualification plan for Exposure Response (E-R) analyses;
- Identify practical steps to guide the development of credible E-R models.
Description:
This webinar addresses gaps in foundational training on core Exposure–Response (E-R) principles relevant to drug development and clinical pharmacology practice. The presentation will explore practical steps to develop credible, fit-for-purpose E-R models aligned with best practices across the drug development continuum. Learners who complete this activity will enhance their knowledge of foundational E-R concepts, strengthening problem solving and critical thinking skills that can be directly applied to clinical pharmacology and regulatory decision-making settings.
Priya Jayachandran
Quantitative Pharmacologist
Regeneron Pharmaceuticals, Inc.
Priya Jayachandran, PharmD, MSE is a Quantitative Pharmacologist in the Drug Safety and Pharmacometrics Group of Research and Development Sciences at Regeneron Pharmaceuticals, Inc. Prior to her present role, she was a Pharmacometrician in the Global Pharmacometrics Group at Pfizer, Inc. Priya earned a Bachelor of Science in Chemical Engineering from Worcester Polytechnic Institute, a Master of Science in Chemical Engineering from the University of California Berkeley, and a Doctor of Pharmacy from the University of California San Francisco (UCSF). She completed her postdoctoral training at UCSF in the NIH T32 Clinical Pharmacology and Therapeutics Fellowship Program. Priya is an Associate Editor for the ASCPT Journal CPT: Pharmacometrics & Systems Pharmacology and has served in various leadership roles in the ASCPT Networks & Communities. Her professional interests include model-informed drug development, global health, peer education, and scientific communication.
Joga Gobburu
Gyi Endowed Pharmapreneurship Professor
University of Maryland Baltimore (UMB)
Dr. Gobburu is a Gyi Endowed Pharmapreneurship Professor with the School of Pharmacy and the School of Medicine, University of Maryland (UMB), Baltimore, MD, USA. He held various positions at the US FDA between 1999 and 2011. Under his leadership, a Division of Pharmacometrics was formed at the FDA and several policies were established. He is a world-recognized scientific leader in the area of quantitative disease models and their application to decisions. Dr. Gobburu is best known for transforming the field of Pharmacometrics across the world into a decision-supporting science. He also established a Pharmacometrics Fellowship program at the FDA. He received numerous FDA awards such as the Outstanding Achievement Award. He also received the Outstanding Leadership Award from the American Conference on Pharmacometrics (2008), the Tanabe’s Young Investigator Award from the American College of Clinical Pharmacology (ACCP) (2008), the Sheiner-Beal Pharmacometrics Award from the American Society of Clinical Pharmacology and Therapeutics in 2019 and Sheiner Lecture Award from International Society of Pharmacometrics in 2023. He received the UMB Entrepreneur of the Year in 2024. Dr. Gobburu is on the Editorial Boards of several journals and a Fellow of ACCP, AAPS and International Society of Pharmacometrics. He has published over 120 papers and book chapters. He is co-founder of PumasAI Inc., and Vivpro Corporation.